TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive With $10.4 Billion To Spend In 18 Months, NIH Says Money Will Be Spent Rationally. Funds Will Support R01s February 20, 2009
TCL Archive DCT board Oks New Cooperative Groups For MRI Evaluations In Breast Cancer February 18, 1994